EU may consider deal on Merck's COVID pill after approval procedure begins


12 October 2021 - The European Union may consider signing a supply deal with U.S. drugmaker Merck for its experimental COVID-19 pill, but only after the company starts the process of seeking approval for the drug in the bloc, a senior EU official said on Tuesday.

The EU would consider a joint procurement of molnupiravir, "if Merck engages with EMA", the EU official told Reuters, referring to the European Medicines Agency.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , COVID-19